Novartis Inc header image

Novartis Inc

NOVN

Equity

ISIN CH0012005267 / Valor 1200526

SIX Swiss Exchange (2026-05-26)

CHF 118.44-0.85%

Novartis Inc
UMushroom community rating:

3.96 45 votes No rating yet

NegativeNeutralPositive

About company

Novartis Inc. is a global healthcare company that specializes in the development and distribution of innovative medicines. With a focus on addressing unmet medical needs, Novartis aims to improve and extend the lives of people suffering from serious diseases. The company operates in several core therapeutic areas, including cardiovascular, renal and metabolic diseases, immunology, neuroscience, and oncology. Novartis is known for its commitment to research and development, leveraging advanced technology platforms to create groundbreaking therapies. With a workforce of approximately 78,000 employees representing over 140 nationalities, Novartis has a significant global presence, reaching more than 284 million patients worldwide. The company's strategy revolves around delivering high-value medicines and employing novel access approaches to alleviate some of society's most significant disease burdens.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

26.3%1Y

40.6%3Y

56.2%5Y

Performance

18.4%1Y

18.7%3Y

18.1%5Y

Volatility

287355 M

Market cap (USD)

1,703,951

Daily traded volume (Shares)

88.82 / 87.81

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.96

45 votes

Performance:

3.64

Innovation:

3.95

Society:

3.90

Nature:

3.49

Oliver Frei

Switzerland, 21 Mar 2026

-

Pavle Stojicic

Switzerland, 20 Mar 2026

Great company, wrong year to expect excitement. Own it in 2027 when the patent cliff is behind them and the new drugs are fully ramping.

Lorenzo Castillejo

Switzerland, 19 Mar 2026

Amazing stock

EQUITIES OF THE SAME SECTOR

Fresenius Medical Care AG

Fresenius Medical Care AG Valor: 523134

Annual Return

-50%0%+50%

Risk level

110

-0.28%USD 21.58

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

2.01%USD 21.35

DENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc Valor: 31773200

Annual Return

-50%0%+50%

Risk level

110

-2.15%USD 9.99

Elevance Health Inc

Elevance Health Inc Valor: 26124340

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 387.85

Sanofi SA

Sanofi SA Valor: 1447201

Annual Return

-50%0%+50%

Risk level

110

-0.32%USD 44.15

Intuitive Surgical Inc

Intuitive Surgical Inc Valor: 1631646

Annual Return

-50%0%+50%

Risk level

110

-0.33%USD 436.64

Icon PLC

Icon PLC Valor: 1017575

Annual Return

-50%0%+50%

Risk level

110

-2.51%USD 113.85

Acadia Healthcare Co Inc

Acadia Healthcare Co Inc Valor: 14151414

Annual Return

-50%0%+50%

Risk level

110

1.34%USD 23.49

Surgery Partners Inc

Surgery Partners Inc Valor: 29308003

Annual Return

-50%0%+50%

Risk level

110

0.37%USD 13.45

Olaplex Holdings Inc

Olaplex Holdings Inc Valor: 113471584

Annual Return

-50%0%+50%

Risk level

110

-0.49%USD 2.04

SIX

FactSet

Clearbit

Logos provided by Clearbit